Literature DB >> 34964948

Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice.

Jaeyeong Park1, Eunkyoung Shin1, Ji-Hyun Yeom1, Younkyung Choi1, Minju Joo1, Minho Lee2, Je Hyeong Kim3, Jeehyeon Bae4, Kangseok Lee5.   

Abstract

Acinetobacter baumannii causes multidrug resistance, leading to fatal infections in humans. In this study, we showed that Lys AB2 P3-His-a hexahistidine-tagged form of an antimicrobial peptide (AMP) loaded onto DNA aptamer-functionalized gold nanoparticles (AuNP-Apt)-can effectively inhibit A. baumannii infection in mice. When A. baumannii-infected mice were intraperitoneally injected with AuNP-Apt loaded with Lys AB2 P3-His, a marked reduction in A. baumannii colonization was observed in the mouse organs, leading to prominently increased survival time and rate of the mice compared to those of the control mice treated with AuNP-Apt or Lys AB2 P3-His only. This study shows that AMPs loaded onto AuNP-Apt could be an effective therapeutic tool against infections caused by multidrug-resistant pathogenic bacteria in humans.
© 2022. The Microbiological Society of Korea.

Entities:  

Keywords:  Acinetobacter baumannii; antimicrobial peptide; gold nanoparticle; multidrug-resistant bacteria

Mesh:

Substances:

Year:  2021        PMID: 34964948     DOI: 10.1007/s12275-022-1620-3

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  61 in total

1.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity.

Authors:  Ellen E Connor; Judith Mwamuka; Anand Gole; Catherine J Murphy; Michael D Wyatt
Journal:  Small       Date:  2005-03       Impact factor: 13.281

Review 2.  Nanotechnologies for biomolecular detection and medical diagnostics.

Authors:  Mark Ming-Cheng Cheng; Giovanni Cuda; Yuri L Bunimovich; Marco Gaspari; James R Heath; Haley D Hill; Chad A Mirkin; A Jasper Nijdam; Rosa Terracciano; Thomas Thundat; Mauro Ferrari
Journal:  Curr Opin Chem Biol       Date:  2006-01-18       Impact factor: 8.822

Review 3.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 4.  Insights into Acinetobacter baumannii pathogenicity.

Authors:  Gustavo M Cerqueira; Anton Y Peleg
Journal:  IUBMB Life       Date:  2011-10-12       Impact factor: 3.885

Review 5.  Nanostructured antimicrobial peptides: The last push towards clinics.

Authors:  Jose Vicente Carratalá; Naroa Serna; Antonio Villaverde; Esther Vázquez; Neus Ferrer-Miralles
Journal:  Biotechnol Adv       Date:  2020-07-29       Impact factor: 14.227

6.  Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.

Authors:  Stijn Blot; Koenraad Vandewoude; Francis Colardyn
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

7.  Rapid determination of carbapenem resistance by low-cost colorimetric methods: Propidium Iodide and alamar blue staining.

Authors:  Jiyoon Choi; Jiwon Baek; Daehyuk Kweon; Kwan Soo Ko; Hyunjin Yoon
Journal:  J Microbiol       Date:  2020-03-28       Impact factor: 3.422

8.  Antibiotic penetration of and bactericidal activity within endothelial cells.

Authors:  R O Darouiche; R J Hamill
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

9.  Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria.

Authors:  Ammar Almaaytah; Gubran Khalil Mohammed; Ahmad Abualhaijaa; Qosay Al-Balas
Journal:  Drug Des Devel Ther       Date:  2017-11-03       Impact factor: 4.162

10.  Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells.

Authors:  Chul Hee Choi; Jun Sik Lee; Yoo Chul Lee; Tae In Park; Je Chul Lee
Journal:  BMC Microbiol       Date:  2008-12-10       Impact factor: 3.605

View more
  1 in total

Review 1.  Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years.

Authors:  Yong Chiang Tan; Chandrajit Lahiri
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.